まとめ
臨床試験における倫理的考察と情報に基づいた同意は,実験設計を複雑にし,研究質問に対する決定的な答えを潜在的に防止します. これは,代替的な統計的アプローチと設計につながる可能性があります.
科学分野:
- 臨床研究の方法論 臨床研究の方法論
- バイオエシック バイオエシック
- 実験デザインの実験です.
背景:
- 臨床試験は,統計的および概念的設計において大きな課題に直面しています.
- 倫理的考察,特にインフォームド・コンセントは,試験の実施にますます影響を及ぼしています.
研究 の 目的:
- 臨床試験における倫理問題と実験デザインの複雑な相互作用を探求する.
- 倫理的な制約が,研究質問に明確に答えられる能力に及ぼす影響について議論する.
主な方法:
- 臨床試験設計における倫理原則の概念分析.
- 統計的方法論と実験的アプローチに対する潜在的な影響の検討.
主要な成果:
- インフォームド・コンセントなどの倫理的な要件は,有効性の明確な定量的な証拠を得るのに重大な障害を伴う.
- これらの倫理的制約は,代替または改変された実験設計の使用を必要とする可能性があります.
結論:
- 臨床試験における倫理的要求は,実験設計とデータ解釈に固有の困難をもたらします.
- 不均衡な境界線,フォーカスダウンデザイン,歴史的制御などの戦略は,これらの倫理的および規制上の要求の結果として発生する可能性があります.
さらに関連する動画
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
関連する概念動画
01:22Case Studies
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...